TickerFactsScreenerDevelopers

Atara Biotherapeutics, Inc. (ATRA) — Operating Income

Annual figures by fiscal year, from SEC filings.

2013: -$8.62M2014: -$28.16M2015: -$58.45M2016: -$81.24M2017: -$121.53M2018: -$237.11M2019: -$295.68M2020: -$309.05M2021: -$340.46M2022: -$280.51M2023: -$276.01M2024: -$83.44M2025: $35.86M$35.86M
2013Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025$35.86M+143.0%
2024-$83.44M+69.8%
2023-$276.01M+1.6%
2022-$280.51M+17.6%
2021-$340.46M-10.2%
2020-$309.05M-4.5%
2019-$295.68M-24.7%
2018-$237.11M-95.1%
2017-$121.53M-49.6%
2016-$81.24M-39.0%
2015-$58.45M-107.6%
2014-$28.16M-226.8%
2013-$8.62M—